Post-Transplant Diabetes Mellitus (PTDM) in Heart Recipients
Miroslaw GarlickiAnn Transplant 2005; 10(3): 51-53 :: ID: 496213
Abstract
Diabetes mellitus is a metabolic disorder that is prevalent in the general population, with more than one in five people over 50 years of age presenting with the condition [Van Hooff 2004].In general, (post-transplant) diabetes develops as a result of low or absent insulin output, increased insulin resistance, or a combination of the two. Transplant recipients generally take a combination of immunosuppressive drugs. Not only the calcineurin inhibitors cyclosporine and tacrolimus, but also corticosteroids have been associated with disturbances in glucose metabolic control [Van Dujinhoven 2003]. PTDM shares many similarities with type 2 diabetes and it may be reversible [Davidson et al. 2003]. The incidence of PTDM after heart transplantation is generally higher when compared to other organ transplantations [ISHLT 2004]....
Keywords: Post-Transplant
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






